Citi Pharma Limited has received regulatory approval from the Competition Commission of Pakistan to acquire the entire shareholding of Pakheim International Pharma.
The deal marks another consolidation in the local pharmaceutical industry as listed players scale up through acquisitions.
With regulatory clearance secured, Citi Pharma moves to complete the transaction and expand its footprint in the pharmaceutical market.
Consolidation among listed drugmakers continues as companies look to grow through strategic buys.